PRD1 噬菌体结构的分子模型

执行摘要:PEG 免疫原性的应知事项

PegyLation是一项改善药物输送系统的突破性技术,但它也有缺点:它可以引发免疫反应,降低药物疗效和安全性。这个想法是为研发领导者设计的,简而言之,它表明了我们如何克服这一挑战。它总结了最新的趋势和机会、聚乙二醇脂质结构、LNP 的组成和特性,以及哪些药物参数会影响其免疫原性和效率。了解更多信息并与您的网络共享:

INSGENENGWHP101133-CAS-Insights-PEGylated-LNPs-Fanned-Image

下载执行摘要

Related CAS Insights

Emerging Science

16 billion reasons for hope: How biomarkers are reshaping cancer outcomes

March 20, 2024

Read article
Emerging Science

2024 年值得关注的科学突破新兴趋势

December 28, 2023

Read article
Emerging Science

Biomarkers: The key to earlier cancer detection and patient outcomes

February 9, 2024

Read article

Gain new perspectives for faster progress directly to your inbox.